Cancer

News

COSMIC database matches drugs to cancer mutations

The world's largest database of cancer mutations can now be used to link mutations with drug treatments in what promises to be a step forward in precision oncology.

News

NICE axes funding for MSD's Keytruda in bladder cancer despi...

NICE has axed funding for MSD’s Keytruda for second-line advanced bladder cancer in final guidance, despite an appeal from the company.

News

Businessmen trading stocks online. Stock brokers looking at graphs, indexes and numbers on multiple computer screens. Colleagues in discussion in traders office. Business success concept.

Rubius launches $200m IPO to fund red blood cell therapies

Rubius Therapeutics has announced the pricing of its Nasdaq IPO, aiming to raise $200 million towards its novel cell therapies targeting cancer and autoimmune diseases.

News

Takeda buys Maverick as T-Cell engager research hots up

Takeda is taking its option to buy the privately held biotech Maverick Therapeutics and its T-Cell engager cancer therapies for $525 million, as research into the technology gathers pace.

News

Roche's Tecentriq loses bladder cancer use as FDA crackdown ...

Roche's Tecentriq is the latest medicine to fall foul of a crackdown by the FDA on drugs that have failed to live up to their early promise.

News

Novartis' canakinumab falls short in phase 3 lung cancer tri...

Novartis’ attempt to treat cancer with the anti-inflammatory drug canakinumab was always a long shot, but it’s nevertheless a disappointing feeling when things don’t work out.

COSMIC database matches drugs to cancer mutations

NICE axes funding for MSD's Keytruda in bladder cancer despi...

Rubius launches $200m IPO to fund red blood cell therapies

Takeda buys Maverick as T-Cell engager research hots up

Roche's Tecentriq loses bladder cancer use as FDA crackdown ...

Novartis' canakinumab falls short in phase 3 lung cancer tri...

Consolidating data strategy for global success: Insights fro...

How to meet your physicians where they are online

Cancer

Editor's Picks